神经节苷脂联合复方丹参片在治疗难治性癫痫临床观察

来源期刊：广州医药 | 38-40 发布时间：2021-11-30 收稿时间：2025/11/13 17:03:28 阅读量：14

作者：: 潘阳新,

陈健,

钟水生,

潘梦秋,

杨慧,

关键词：: 神经节苷脂复方丹参片癫痫; Ganglioside Compound salvia miltrorrhiza tablet Ovarian function

DOI：: 10.3969/j.issn.1000-8535.2016.02.013

收稿时间：: 2015-11-01
修订日期：
接收日期：
引用总数：: 0

目的观察单唾液酸四己糖神经节苷脂联合复方丹参片在治疗难治性癫痫的脑保护作用。方法选取2010年1月—2015年10月于我院进行治疗的80例难治性癫痫患者为研究对象,随机分为对照组和治疗组。对照组患者给予常规抗癫痫药物治疗,而治疗组患者在对照组治疗基础上给予单唾液酸四己糖神经节苷脂联合复方丹参片治疗。治疗一疗程后,对两组患者进行疗效判定;并分别在治疗前后使用韦氏成人智力量表(WAIS-RC)和韦氏记忆量表(WMS-RC)对两组患者的智商和记忆商进行测评,并比较分析。结果 ①观察组患者的治疗总有效率为97.5%高于对照组的87.5%(P<0.05)。②治疗后,观察组患者的语言智商、操作智商、总智商和记忆商得分分别为(95.4±8.5)分、(94.8±12.5)分、(92.8±7.5)分和(93.5±8.2)分,均高于治疗前的(89.5±7.2)分、(91.5±10.1)分、(88.5±6.9)分和(82.5±10.0)分,且也均高于对照组治疗后的(75.4±6.8)分、(80.6±9.8)分、(80.1±5.9)分和(76.9±8.2)分,以上差异均有统计学意义(P<0.05)。治疗后,对照组患者的智商和记忆商均见的下降,均低于治疗前各分数,以上差异有统计学意义(P<0.05)。结论神经节苷脂联合复方丹参片治疗难治性癫痫临床效果显著,且具有一定的脑保护效果,可为以后临床治疗难治性癫痫患者提供参考依据。

Objective To observe the cerebral protective effects of monomial four hexose ganglioside combined with compound salvia miltrorrhiza tablets (CSMT) in patients with refractory epilepsy. Methods 80 patients with refractory epilepsy patients treated in our hospital between January 2010 and October 2015 were randomly divided into control group and treatment group. The control group patients were treated with conventional antiepileptic drug therapy, and the treatment group patients were treated with monomial four hexose ganglioside, CSMT and conventional antiepileptic drug therapy. The efficacy in two groups' patients was determined after a course of treatment. The IQ and memory quotient in two groups' patients before and after treatment were evaluated by the Wechsler Adult Intelligence Scale (WAIS-RC) and the Wechsler Memory Scale (WMS-RC) respectively and comparative analysed. Results ①The total effective rate in the treatment group (97.5%) was significantly higher than that in the control group (87.5%) (P<0.05). ②The verbal IQ (95.4±8.5), performance IQ (94.8 ± 12.5), total IQ (92.8 ± 7.5) and memory quotient (93.5 ± 8.2) scores in the treatment group after treatment were significantly higher than those before treatment (89.5 ± 7.2), (91.5 ± 10.1), (88.5 ± 6.9), (82.5 ± 10.0) respectively, and also were significantly higher than those in the control group after treatment (75.4 ± 6.8), (80.6 ± 9.8), (80.1 ± 5.9) and (76.9 ± 8.2) respectively (P<0.05). The IQ and memory quotient in the control groups' patients after treatment were significantly decline and lower than before treatment, which had a statistically significant difference (P<0.05). Conclusion Ganglioside combined with CSMT in the treatment of refractory epilepsy can receive significant clinical effect and own a certain brain protective effect, which provide reference to the future clinical treatment of refractory epilepsy patients.

1、夏敏,武士京,孔庆霞,等.左乙拉西坦添加治疗成人难治性癫痫部分性发作的临床疗效和脑电图分析[J]. 中风与神经疾病杂志,2015,32(2):168-170.

2、谈宇樑.中药联合单唾液酸四己糖神经节苷脂纳治疗脑外伤癫痫观察[J]. 中国实用神经疾病杂志,2015,18(3):98-99.

3、何彩英.长程录像脑电图监测在纠正儿童医源性难治性癫痫中应用的护理配合[J]. 中国实用护理杂志,2014,30(14):46-48.

4、路辉,王炎焱,陈馥,等.癫痫散配合西药治疗难治性癫痫50例[J]. 中国中西医结合杂志,2001,21(6): 465.

5、孙伟,毛薇,王玉平,等.抗癫痫药对癫痫认知功能的影响[J]. 中国康复理论与实践,2010,16(7):648-649.

6、崔萍萍,李成荣,李秋,等.生酮饮食对难治性癫痫患儿 Th 细胞亚群的影响[J]. 中华微生物学和免疫学杂志,2015,3:225-231.

7、李鸿涛,李哲,冯磊,等.余瀛鳌治疗难治性癫痫经验[J]. 中医杂志, 2015,56(1):14-16.

8、王秀英,廖寅婷,麦坚凝.儿童良性癫痫伴中央颞区棘波患儿的视觉记忆功能研究[J]. 广州医药,2014年,45(4): 7-9.